David Roth, MD, PhD, describes the legacy and mission of the Center for Personalized Diagnostics (CPD), a joint effort of Penn Medicine and the Abramson Cancer Center. Dr. Roth’s focus includes the collaborative efforts between oncologists and pathologists at the CPD and the techniques and prognostic benefits of gene panel diagnostics.
Related Links
Published
August 14, 2014
Created by
BROADCASTMED